OBJECTIVE: To assess relative biological effectiveness (RBE) of (131)I radiation relative to (60)Co gamma rays in glioblastoma spheroid cells. MATERIALS AND METHODS: : In this experimental study, glioblastoma spheroid cells were exposed to (131)I radiation and (60)Co gamma rays. Radiation induced DNA damage was evaluated by alkaline comet assay. Samples of spheroid cells were treated by radiation from (131)I for four different periods of time to find the dose-response equation. Spheroid cells were also exposed by 200 cGy of (60)Co gamma rays as reference radiation to induce DNA damage as endpoint. RESULTS: Resulted RBE of (131)I radiation relative to (60)Co gamma rays in 100 µm giloblastoma spheroid cells was equal to 1.16. CONCLUSION: The finding of this study suggests that (131)I photons and electrons can be more effective than (60)Co gamma rays to produce DNA damage in glioblastoma spheroid cells.
OBJECTIVE: To assess relative biological effectiveness (RBE) of (131)I radiation relative to (60)Co gamma rays in glioblastoma spheroid cells. MATERIALS AND METHODS: : In this experimental study, glioblastoma spheroid cells were exposed to (131)I radiation and (60)Co gamma rays. Radiation induced DNA damage was evaluated by alkaline comet assay. Samples of spheroid cells were treated by radiation from (131)I for four different periods of time to find the dose-response equation. Spheroid cells were also exposed by 200 cGy of (60)Co gamma rays as reference radiation to induce DNA damage as endpoint. RESULTS: Resulted RBE of (131)I radiation relative to (60)Co gamma rays in 100 µm giloblastoma spheroid cells was equal to 1.16. CONCLUSION: The finding of this study suggests that (131)I photons and electrons can be more effective than (60)Co gamma rays to produce DNA damage in glioblastoma spheroid cells.
In nuclear medicine, 131I is one of the most commonly used radioisotopes in treatment of thyroid. Application of this radioisotope in treatment
of thyroid-related diseases has been one of the
most successful treatments in radiation therapy.
Recently some studies have been performed in
order to assess the treatment capability of 131I radiation in central nervous system (CNS) tumors.
Application of 131I labeled with metaiodobenzylguanidine (MIBG) has shown promising therapeutic effects in treatment of neuroblastoma. In one
study, performed on 42 patients with advanced
neuroblastoma, the overall survival for stage three
and stage four were 75 and 69% respectively (1).
Post-surgery radioimmunotherapy of patients with
glioblastoma has also shown promising results in
controlling the progression of the residual tumor.
Direct injection of 131I labeled antitenascin antibodies into the tumor mass of 30 patients has lead
to overall response rate of 34.7% (2). Because of
increasing studies in therapeutic application of
131I, there is a need to further study the basic radiobiology of this radioisotope. For this reason and in
order to establish appropriate protocols in medical application of 131I, we measured relative biological effectiveness of 131I, as a comprehensive
radiobiological concept. Relative biological effectiveness (RBE) is defined as the ratio of a dose of
standard radiation to the dose of test radiation to
produce the same biological effects. Although 250
kVp X-ray was the common standard radiation to
determine the RBE, the International Commission
on Radiation Protection (ICRP) recommended in
their 92th report to use gamma rays of 60Co as reference radiation (3) and therefore was chosen as
reference in this study. In spite of the fact that 60Co
gamma rays and 131I radiation as two low linear energy transfer (LET) radiations have the same
quality factor (QF), they seem to exert different biological effects. Determination of RBE is
a comprehensive way to compare effects of these
two low LET radiations. ICRP recommended in
1990 a quality factor of 1 for all low LET radiations such as photons and electrons but in vitro
studies have shown different biological effects
for photons and electrons (4). Although ICRP in
2007 accepted that low LET radiations have different effects on cells but it still continues to use
quality factor of 1 for all low LET radiations (5).Depending on the energy, low LET radiations have
different biological effects and different RBEs. In
general, low energy radiations are more effective in
comparison to high energy radiations. For example,
29 kVp X-ray is more effective than 200-220 kVp
X-rays (6) or Tritium beta ray (5.7 keV) is much
more effective than 15 MeV electrons (7). In order to
compare biological effects of two types of radiation a
variety of endpoints can be used. Radiation induced
DNA damage to detect the primary effects of radiation on biological cells can be used as the biological
endpoint. In addition, there are efficient and robust lab
techniques such as comet assay or single cell gel electrophoresis in which extent of DNA damage in cells,
so called tail moment, is a measurable quantity and
have been used for more than two decades (8, 9).In this study, in order to understand the basic
radiobiology of 131I radiation and to compare biological effects of two low LET radiations, we investigated the relative biological effectiveness of
131I radiation to 60Co gamma rays in spheroids of
U87MG cell line using the comet assay.
Materials and Methods
Thermoluminescent dosimeter (TLD) calibration
In this experimental study, TLD-100 chips with
dimensions of 1.3×1.3×0.9 mm3
, density of 2.64 g/cm3
and average atomic number of 8.2 were used as
tissue equivalent dosimeter. Twelve TLD chips were
annealed at 400˚C for 1 hour followed by second an-w
nealing at 100˚C for 24 hours. For calibration purpose,
TLD chips in four groups of three were irradiated by
60Co gamma rays of doses 10, 30, 50, 70, 90 and 110
cGy. In order to apply the correction factor in the calibration equation, a second exposure was performed at
different doses of 5, 10, 40, 60, 80 and 100 cGy. During irradiation, a tissue equivalent plexiglass layer was
covered on TLD chips to provide build up region of
60Co photons. Thermo luminescent reading was performed by TLD reader Harshaw/Bicron model 3500.
Dosimetry of 131I radiation by TLD
In order to determine the dose-time equation of 131I
radiation in TLD chips, each group of TLD chips was
covered by a thin layer of plastic and was embedded
in a flask. All flasks were filled by 10 ml of medium
and 10 mCi of 131I. TLD groups were exposed for 30,
60, 90, 120 and 150 minutes respectively
Cell line
U87MG cell line was obtained from Pastor Institute of Iran. It was cultured in Minimal Essential
Medium (MEM) (Gibco, USA) containing 10% Fetal Bovine Serum (FBS) (Gibco, USA) and 500µ/
ml of penicillin (Sigma, USA).
Monolayer culture
Glioblastoma cells were cultured as a monolayer
in T-25 flasks (NUNC, Denmark) under the incubation condition of 37˚C, 5% CO2
and humidified atmosphere of 95%. In subculturing process,
Phosphate BufferSaline (PBS) was used for washing cells and 1 mM ethylenediaminetetraacetic acid
(EDTA) was used for trypsinizing the cells.
Spheroid culture
Spheroids were cultured by liquid Overlay technique. Number of 105
cells were cultured in 100
mm dishes that were coated with a layer of 1%
agar with 10 ml of MEM containing 10% FBS. The
plates were incubated in 5% CO2
, 37˚C and humid-h
ified atmosphere. Every three days half of medium
was removed and replaced with fresh medium.
Spheroid growth curve
Each spheroid cell was transferred into a multiwell plate (24 wells/plate) (NUNC, Denmark) that
was coated by 1% agar with 10ml of MEM supplemented with 10% FBS. The spheroid cells were
incubated at 5% CO2
, 37˚C. In order to calculate
the volume of each spheroid according to the equation V (Volume)=a×b2×π/6, two perpendicular diameters of the spheroid (a and b) were measured
to find the growth equation V(t)=V0×ekt, where V0
is the initial volume of spheroid and k represents
gradient of logarithmic phase of the growth curve
Cell treatment by 60Co radiation
Glioblastoma Spheroid cells were irradiated by
photons of 60Co as reference radiation. Theratron
780 unit at dose rate of 80 cGy per minute was
used to deliver dose of 200 cGy to spheroid cells.
Flasks containing spheroid cells were sufficiently
filled with medium and covered the cells to provide build up layer of 60Co photons. Exposure factors were set at field size of 12×12 cm2
and SSD of
70 cm. In order to measure damages based on factors other than 60Co radiations, one flask was not
exposed as the control group. Resulted damages of
unexposed spheroids were used to determine net
damages of 60Co radiation.
Cell treatment by 131I radiation
In order to find dose-response equation of 131I radiation in glioblastoma cells, spheroids in various
culture flasks were exposed for different exposure
times (30, 60, 90 and 120 minutes). Initial activity
of 10 mCi 131I was poured into each flask of spheroids. The control sample was also considered in
order to find net damages of 131I radiation.
Viability test
In order to evaluate viability of cells in each category, a suspension of each category was mixed
with Trypan blue. The viability test determines the
ability of cells to recover its viability. In each step,
before counting the cells under microscope, viability test was performed to determine the health status of cells. The ratio of cell suspension to trypan
blue was 9:1. The mixture was observed by a light
microscope (Leica, DMLS, USA) and all the blue
cells were considered as dead cells. Percentage of
unstained cells, as healthy cells, to the total cells
represented the viability.
Comet assay
Induced DNA damage in U87MG cells exposed
to 60Co radiation and 131I radiation were determined by alkaline comet assay. Microscope slides
were coated with 1% normal melting point agarose
(Merck, Germany). After counting spheroid cells
in hemocytometer, approximately 10000 cells in
10 µl PBS were mixed with 100 µl of 5% low
melting agarose (Merck, Germany). The cell suspension was then poured on the coated microscope
slide. After getting the suspension on the slides solidified, they were immersed in lysis buffer (2.5 M
NaCl, 100 mM EDTA, 10 mM Tris-base with 1%
Triton X-100, pH=10) and incubated for one hour.Subsequently, the slides were removed from
the buffer and transferred into a denaturation
buffer (300 mM NaOH, 1mM EDTA, pH=13) in
a horizontal gel electrophoresis tank (Cleaver Scientific Ltd, CSL-COM20). Electrophoresis was
performed for 30 minutes at the voltage of 1 V/
cm and amperage of 300 mA. After electrophoresis, alkaline was neutralized by Tris buffer (0.4
M Tris-HCl, pH=7.5) and the slides were then immersed in ethidium bromide. In order to take photograph of damaged cells, slides were transferred
under a fluorescent microscope (Zeiss, Axioskop
2 plus) with an ethidium bromide filter (excitation
filter, 535 nm; emission filter, 610 nm) and a CCD
camera (Hitachi, KP-D20BP).
Evaluation of DNA damage
For each sample of cells three slides were considered and for each slide 100 cells were scored. DNA
damage was quantified as increase in tail moment.
The intensity of comet tail relative to the head of comet represented DNA damage. In most experiments,
cell damages with respect to the extent of damaged
DNA, could be scored from no damage (class one)
to total damage (class five). Highly damaged form
of DNA may result in apoptosis. DNA tail moments
were analyzed by comet score software.
Determination of RBE
RBE is the ratio of the dose of reference radiation to
a dose of test radiation to produce a similar endpoint.
In this experimental study, 60Co was used as reference
radiation and net induced DNA damage by 200 cGy
of this radiation was considered as the endpoint. In
order to find dose of 131I beta radiation (Dtest) which
produces the same endpoint, dose-response equation of 131I radiation was determined. In this equation,
response was equaled to the induced endpoint (response) by 200 cGy of 60Co gamma photons. Finally,
ratio of 200 cGy to the determined dose of 131I (Dtest)
beta radiation was considered as RBE.
Results
1I and related absorbed dose
in TLD chips are represented in table 1. Corresponding time-dose equation is shown in figure 1
indicating linearity for this relationship (R2
=0.997).Absorbed doses in TLD chips by 131I radiationAbsorbed doses in TLD chips by irradiation of 131I for
30, 60, 90, 120 and 150 minutes. (Error bars represent Mean
± SEM of 3 replicates).The U87MG cell line was cultured as spheroid forms.
Growth curve of spheroids is shown in figure 2 and
this curve was used to determine the doubling time
(67 hours). It lasted 11 days to have spheroids with
Relative Biological Effectiveness of 131I Radiation
100 μm in diameter. After exposure of cells, induced
DNA damage in cells was evaluated as tail moments
by comet assay. Figures 3A-3G represent microphotographies of the 100 μm spheroid cells in control and
treated groups. Apoptosis as a result of highly damaged DNA was also observed. (some DNA damages
such as DNA-cross link, DSB and bulky DNA adducts, if not repaired, may lead to apoptosis). Irradiation was performed in two different places for 131I and
60Co irradiation and due to different environmental
conditions, induced base damage in control groups
for 131I and 60Co irradiation were not similar.Growth curve of U87MG cell line in the spheroid cultures (y=6999e0.561X). The log phase of curve is in days 2 to
5 and gradient of this phase is used to measure the volume
doubling time (calculated doubling time is 67 hours). (Error
bars represent Mean ± SEM of 3 replicates).Comet Assay photos of U87MG cells of 100μm spheroids after irradiation with 131I and 60Co. Microphotographies are
representative of the following slides: A. control for 60Co, B. control for 131I, C. irradiated by 131I for 30 minutes, D. irradiated
by 131I for 60 minutes, E. irradiated by 131I for 90 minutes, F. irradiated by 131I for 120 minutes, G. irradiated by 200 cGy of 60Co.For each category of cells the average tail moment,
was determined as induced DNA damage. Table 2
represents absorbed dose and corresponding DNA
damage as tail moments in glioblastoma spheroid
cells. Dose-response equation of 131I radiation was
Y=0.008X+0.564, where X and Y are absorbed dose
in cGy and tail moment in µm as response of cells to
the radiation respectively (Fig 4). In order to obtain
net damage, DNA damage in control group was subtracted from treated groups. Resulted dose-response
equation for net damage induced by 131I radiation
was Y=0.008X+0.116. With respect to this equation,
171.1 cGy of 131I radiation and 200 cGy of 60Co radiation have the same biological effect. Therefore, ratio of 200 cGy to 171.1 cGy, equal to 1.16, was found
to be the RBE of 131I radiation to 60Co radiation. RBE
depends on many factors such as dose, dose rate, cell
line and endpoint. RBE in this experiment is resulted
from the dose-response equation that showed increasing the exposure time to 131I radiation, increases DNA
damage in glioblastoma tumor cells. Also the correlation coefficient showed that there is good linearity
between absorbed dose of 131I in 100μm spheroid cells
and resulted DNA damage (R2
=0.982). Comparative
chart for irradiated groups by radiations of 131I and
60Co is shown in figure 5.
Fig 4
Resulted tail moments in U87MG cell lines of 100μm
spheroids relative to absorbed doses of 131I irradiation (Error
bars represent Mean ± SEM of 3 replicates).
Induced tail moments in glioblastoma spheroid
cells by 131I and 60Co radiationsResulted tail moments in U87MG cell lines of 100μm
spheroids relative to absorbed doses of 131I irradiation (Error
bars represent Mean ± SEM of 3 replicates).Comparative chart for induced tail moment in irradiated groups by radiations of 131I and 60Co (Error bars represent SD of 3 replicates).
Discussion
RBE is a complex concept to compare a test radiation with reference radiation in a comprehensive way. RBE depends on dose, dose rate, LET,
expose conditions, cell type and endpoint (10) and
is used for radiation treatment planning and radiation protection. For a good treatment planning by
ion beams, in order to focus maximum RBE to the
center of tumor, knowledge about dependence of
RBE to depth is necessary. In radiation protection,
RBE is a key factor to derive QF (6).In this study, RBE of 131I radiation was evaluated relative to 60Co gamma rays in an experimental approach (10). RBE of 1.16 indicated that 131I
radiation is more effective than 60Co radiation to
produce DNA damage in 100 µm glioblastoma
spheroid cells. According to previous studies, RBE
of 131I is in the range of 0.3 to 1(11). This variation
may be due to factors affecting RBE.One of the affecting factors on RBE is energy.
Experimental studies have shown that low energy
photons and electrons are more effective than high
energy photons or electrons to produce biological
damage (6). For 60Co and 131I radiation radiobiological mechanisms are different which result in
different biological effects. High energy photons
of 60Co as indirect ionizing radiation produce energetic secondary electrons by Compton scattering
and photoelectric interaction whereas 131I radiation
consists of photons and beta particles. Beta particles of 131I have average range of one millimeter
therefore increase DNA damage due to the cross
fire phenomenon (12, 13). Capability of 131I beta
particles in producing considerable damages in
small clusters of cells has made it a promising radioisotope in target therapy of small tumors. After successful use of 131I in thyroid cancer treatments, researchers have focused on treatment of
other malignancies such as hepatocellular carcinoma (HCC) and pheochromocytoma (PCC)
by radio iodine (14, 15). 131I-MIBG (Metaiodobenzylguanidine) is a radio labeled antibody in
target therapy of CNS tumors which uses 131I
to damage tumor cells (16). Since CNS tumors
are resistant to radiation and therapies such as
chemotherapy and external beam therapy are
restricted because of proximity of critical organs to these tumors, target therapy can be an
alternative.Findings of this study can be used in radiation
therapy or target therapy of glioblastoma tumors.It is clear that comparison between biological
effects of 131I radiation and 60Co gamma rays at
the DNA scale forms the basis of the information
for understanding radiobiology of 131I but more
comprehensive studies are needed in this field.
Type of cell line is also the other factor which affects the RBE. Further studies are recommended
to evaluate biological effects of 131I radiation on
various cell lines. Also, in this study, 131I radiation
was evaluated at low dose rate relative to 60Co
gamma rays at high dose rate. Biological effect
of a radiation is affected by dose rate where at
low dose and low dose rate, cellular repair mechanism operates and reduces biological effects of
radiation (6). Therefore, further studies are recommended to assess RBE of 131I at various dose
rates to find possible relation between dose rate
and RBE of 131I radiation. Relationship between
dose rate and RBE will be important in health
risks in which exposure to the radioiodine occurs
at various dose rates. Moreover, it is important in
radiation therapy to find the optimal dose rate to
achieve optimum treatment.
Conclusion
This study was an attempt to measure the RBE
of 131I in a new approach with high sensitive techniques at the DNA scale. It is indicated that beta
particles of 131I, due to cross fire phenomenon,
have an important role in inducing considerable
damage in small spheroid cells. The result of this
study (RBE of 1.16) differs from previous findings, indicating dependency of RBE to the conditions of the experiment.
Table 1
Absorbed doses in TLD chips by 131I radiation
Irradiation time (minutes)
Absorbed dose (cGy)
30
40
60
102
90
164
120
231
150
277
Table 2
Induced tail moments in glioblastoma spheroid
cells by 131I and 60Co radiations